Vaxxinity Inc. (VAXX) Fundamentals

Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications.
SHARE INFORMATION
Market Cap$ 265,910,296
Shares Outstanding126,023,837
Float33,872,109
Percent Float26.88%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 66,000
Latest Fiscal EPS$ -1.80
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions43
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months4,677,397
Institutional Holdings Percent22.0%
Institutional Sold Previous 3 Months202,888
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months1,224,349
Insider Holdings Percent8.9
Insider Sold Previous 3 Months779,743
Insider Shares Owned11,170,936
TRADING INFO
52 Week High$ 22.77
52 Week Low$ 1.51
52 Week High Change$ 0.00
21 Day Moving Average$ 2.2381
21 Day Extended Moving Average$ 2.1998
50 Day Moving Average$ 2.1456
50 Day Extended Moving Average$ 2.2865
200 Day Moving Average$ 4.071
200 Day Extended Moving Average$ 4.9512
10 Day Average Volume331,775
20 Day Average Volume291,405
30 Day Average Volume279,149
50 Day Average Volume282,500
Alpha-0.100404
Beta-1.4573
Standard Deviation0.412984
R20.046698
7 Day Price Change$ -0.03
7 Day Percent Change-1.4%
21 Day Price Change$ -0.23
21 Day Percent Change-9.83%
30 Day Price Change$ -0.26
30 Day Percent Change-10.97%
Month to Date Price Change$ -0.27
Month to Date Percent Change-11.34%
Quarter to Date Price Change$ 0.54
Quarter to Date Percent Change34.39%
180 Day Price Change$ -2.24
180 Day Percent Change-51.49%
200 Day Price Change$ -2.38
200 Day Percent Change-53.01%
Year to Date Price Change$ -3.50
Year to Date Percent Change-62.39%

Vaxxinity Inc. (VAXX) Key Ratios

PROFITABILITY
EBIT Margin-231,285.7%
EBITDA Margin-228,710.2%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin81.6%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 49,000
Revenue Per Share$ 0.0004
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.70
Total Debt To Equity0.10
Int Coverage-263.60
Current Ratio4.20
Leverage Ratio3.20
Quick Ratio3.70
Long Term Debt To Capital0.09
VALUATION MEASURES
PE Ratio-1.30
Enterprise Value$ 167,357,295
Price to Sales4,829.3037
Price to Free Cash-3.90
PE High Last 5 Years0.00
Price To Book2.70
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book2.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.10
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-81.58
Return on Equity511.55
Return on Capital-99.79

Vaxxinity Inc. (VAXX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorArmanino LLP
CEOMei Mei Hu
Emplyoees89
Last AuditUQ
CIK0001851657
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address1717 Main Street
Suite 3388
Dallas, TX 75201
Websitehttps://www.vaxxinity.com
Facsimile-
Telephone+1 254 244-5739
Email-


Your Recent History
NASDAQ
VAXX
Vaxxinity
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.